Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 11:41 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1657–1680 of 8,271 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Age Clear all

Conditions: Hepatobiliary Cancer, Cholangiocarcinoma, Liver Metastases
Interventions: Resistance Training, Aerobic Training; Behavioral
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 65 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Chordomas, Chondrosarcomas
Interventions: Proton Therapy; Radiation
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Physical Activity
Interventions: AgingPLUS, Active Control Group; Behavioral
Lead sponsor: Colorado State University; Other
Eligibility: 45 Years to 75 Years
Enrollment: 402 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Fort Collins, Colorado

Conditions: Smith-Magenis Syndrome, Circadian
Interventions: tasimelteon, placebo; Drug
Lead sponsor: Vanda Pharmaceuticals; Industry
Eligibility: 3 Years to 65 Years
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 4
States / cities: Santa Monica, California • Baltimore, Maryland • Chevy Chase, Maryland + 1 more

Conditions: Raman Spectroscopy, Children, Only
Interventions: Feeding trial; Other
Lead sponsor: Utah State University; Other
Eligibility: 5 Years to 18 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 1
States / cities: Logan, Utah

Conditions: Non-verbal Learning Disorder, Autism Spectrum Disorder, Autism
Interventions: Open-label Treatment with Omega-3 Fatty Acids + Inositol, Open-label Treatment with N-acetylcysteine; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 5 Years to 17 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Adolescent - Emotional Problem
Interventions: anonymous social support, psychoeducation, online resources; Other
Lead sponsor: Northwell Health; Other
Eligibility: 14 Years to 17 Years
Enrollment: 212 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Glen Oaks, New York

Conditions: Paget's Disease of Bone
Interventions: Not listed
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2024
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Neovascular (Wet) Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, Diabetic Retinopathy
Interventions: SCD411 0.05mL (2mg); Drug
Lead sponsor: Sam Chun Dang Pharm. Co. Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 4
States / cities: Stuart, Florida • Winter Haven, Florida • Lemont, Illinois + 1 more

Conditions: Hearing Loss, Sensorineural
Interventions: Acoustic distortion of speech; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Individuality, Healthy, Asthma, Immune System and Related Disorders
Interventions: Pneumococcal Vaccination; Biological
Lead sponsor: Michigan State University; Other
Eligibility: 18 Years and older
Enrollment: 61 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: East Lansing, Michigan

Conditions: Alcohol Use Disorder
Interventions: MRI: Brain Imaging data collection; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 60 Years
Enrollment: 82 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathies
Interventions: Not listed
Lead sponsor: National Institute of Environmental Health Sciences (NIEHS); NIH
Eligibility: 2 Years and older
Enrollment: 1,056 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2003
U.S. locations: 3
States / cities: Bethesda, Maryland • Research Triangle Park, North Carolina • Madison, Wisconsin

Conditions: Nosocomial Pneumonia
Interventions: Ceftolozane/Tazobactam; Drug
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 7 Days to 17 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 6
States / cities: Orlando, Florida • Rochester, Minnesota • New York, New York + 3 more

Conditions: Mental Disorders
Interventions: Testing (MRS, US, DEXA, blood tests); Procedure
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 6 Years to 18 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: HIV Infections, Measles
Interventions: Attenuvax, M-M-R-II; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 6 Months to 7 Months
Enrollment: 270 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Ends 2001
U.S. locations: 43
States / cities: Birmingham, Alabama • Long Beach, California • Los Angeles, California + 29 more

Conditions: Enteric Hyperoxaluria, Primary Hyperoxaluria, Hyperoxalemia
Interventions: ALLN-177; Drug
Lead sponsor: Allena Pharmaceuticals; Industry
Eligibility: 12 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 4
States / cities: Scottsdale, Arizona • Little Rock, Arkansas • New Haven, Connecticut + 1 more

Conditions: Lung Cancer
Interventions: vinorelbine tartrate; Drug
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Eligibility: 65 Years and older
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2007
U.S. locations: 13
States / cities: Scottsdale, Arizona • Urbana, Illinois • Cedar Rapids, Iowa + 10 more

Conditions: Venous Thromboembolism
Interventions: Rivaroxaban (Xarelto, BAY59-7939), Standard of Care; Drug
Lead sponsor: Bayer; Industry
Eligibility: Up to 17 Years
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 23
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Los Angeles, California + 19 more

Conditions: Chronic Pain
Interventions: Medical Cannabis; Other
Lead sponsor: Florida State University; Other
Eligibility: 50 Years and older
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Medium-chain Acyl-CoA Dehydrogenase Deficiency
Interventions: Sodium phenylbutyrate; Drug
Lead sponsor: Jerry Vockley, MD, PhD; Other
Eligibility: 4 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Long QT Syndrome
Interventions: QTScreen ECG Recorder; Device
Lead sponsor: QT Medical, Inc.; Other
Eligibility: 2 Weeks to 4 Weeks
Enrollment: 4,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 3
States / cities: Lynwood, California • Torrance, California

Conditions: Kidney Cancer, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Neuroblastoma, Neutropenia, Sarcoma
Interventions: voriconazole; Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 2 Years to 11 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 7
States / cities: Orange, California • San Diego, California • Bethesda, Maryland + 4 more

Conditions: Acute on Chronic Systolic Congestive Heart Failure
Interventions: Reversible Pulmonary Artery Banding, GORE-TEX DualMesh EMERGE PLUS Biomaterial; Procedure
Lead sponsor: Loma Linda University; Other
Eligibility: Up to 4 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Loma Linda, California

Search by objective public record fields.

Senior Adult Hepatobiliary Prehab Study

Proton Radiation for Chordomas and Chondrosarcomas

AgingPLUS: Promoting Physical Activity in Adults

Evaluating the Effects of Tasimelteon vs Placebo on Sleep Disturbances in SMS

The Effect of a Nutrient Dense Food on the Skin CarotenoidLevels of School Age Children

Natural Treatments for the Management of Emotional Dysregulation in Youth With Non-verbal Learning Disability (NVLD) and/or Autism Spectrum Disorders (ASD)

Loves Company: Combatting Emotional Disturbance in the Digital Age

Pathophysiology of Paget's Disease of Bone

Study of the SCD411 Prefilled Syringe for Treating Adults With Wet Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, or Diabetic Retinopathy

Spectral Dynamics and Speech Understanding by Hearing Impaired People

Vaccination Responses in Young and Older Adults

Brain Functional Connectivity in Alcohol Use Disorder

Study of Families With Twins or Siblings Discordant for Rheumatic Disorders

Safety and Pharmacokinetics of Ceftolozane/Tazobactam in Pediatric Participants With Nosocomial Pneumonia (MK-7625A-036)

Measurement of Cardiometabolic Risk in Antipsychotic-Treated Children

A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group

Study of ALLN-177 in Patients Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia

Vinorelbine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

EINSTEIN Junior: Oral Rivaroxaban in Children With Venous Thrombosis

Reactions of Older Adults Driving After Cannabis Exposure

Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Pediatric and Adults Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)

Long QT Syndrome Screening in Newborns

Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy

Reversible Pulmonary Artery Banding as Simplified Management of End-stage Dilated Left Ventriculopathy in Early Life